Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 3402

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1A
Chunk 3402
---
, Brazil,
    Europe, India, AIRPO, and Thailand. The issued patents have expected expiration dates in 2032, without accounting for any available
    patent term adjustments or extensions. 

    ●
    With
    respect to ODA-611 and ODA-579, our Ocean Sihoma, Inc. subsidiary also obtained an exclusive sublicense from Elkurt under Elkurt’s
    exclusive license from Rhode Island Hospital. Specifically, this Elkurt license includes eight pending utility patent applications
    in the United States, Canada, Brazil, Europe, South Africa, India, Thailand, and ARIPO. 

Licensing
Agreements

Exclusive
License Agreement with Elkurt for (FRG) Antibody

On
July 31, 2020, we entered into an exclusive license agreement, or the FRG License Agreement, with Elkurt, Inc., or Elkurt, for OCX-253.
We further sub-licensed this program to our Ocean Chitorx, Inc. subsidiary on February 25, 2021. We amended the FRG License Agreement
on March 21, 2021, August 31, 2021, March 25, 2022, July 1, 2022, July 2, 2022, August 25, 2022, November 1, 2023 and June 13, 2024.
Pursuant to the FRG License Agreement, we obtained from Elkurt an exclusive, royalty-bearing license under certain patent rights, or
the FRG Patents, and a nonexclusive, royalty-bearing license under certain data, expression and purification methods, information and
other know-how, or the FRG Know-How, relating to anti-Chi311 antibodies, or FRG Antibodies. Under such licenses that we obtained from
Elkurt, or the FRG Licenses, we have the right to make, have made, market, offer for sale, use and sell in all fields of use on a worldwide
basis any products or services that are either covered by the FRG Patents or incorporates or otherwise utilizes any FRG Know-How, or
any materials that are sold in conjunction with any such products or services, in each such case an FRG Product. On January 29, 2020,
Elkurt obtained from Brown University, or Brown, the licenses, with the rights to sublicense, under the FRG Patents and the FRG Know-How,
to grant